Lymphoscintigraphy in head and neck patients treated with primary radiotherapy

Lymphoscintigraphy in head and neck patients treated with primary radiotherapy - SNERT study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON31486

Enrollment

Registered

2008-02-11

Start date

2008-05-05

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

head and neck cancer head and neck squamous cell carcinoma

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with squamous cell carcinoma of the head and neck Scheduled for primary irradiation of the primary tumor and neck Primary tumor accessible for peritumoral injection of radiolabeled colloid No clinical lymph node metastases pretreatment No previous neck pathology or treatment to the primary tumor or neck (surgery, radiotherapy or chemotherapy) that may alter lymphatic drainage

Exclusion criteria

Exclusion criteria: age 80 years

Design outcomes

Primary

Measure	Time frame
Alteration of lymphatic drainage after primary radiation therapy.	—

Secondary

Measure	Time frame
none	—

Countries

Netherlands

Outcome results